BlackRock Health Sciences Trust (NYSE:BME) Share Price Passes Below Fifty Day Moving Average of $42.99

BlackRock Health Sciences Trust (NYSE:BMEGet Rating)’s stock price passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $42.99 and traded as low as $40.56. BlackRock Health Sciences Trust shares last traded at $40.56, with a volume of 22,070 shares changing hands.

BlackRock Health Sciences Trust Stock Down 2.0 %

The business’s 50 day moving average is $42.99 and its 200-day moving average is $43.26.

BlackRock Health Sciences Trust Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Friday, September 30th. Investors of record on Thursday, September 15th will be paid a $0.213 dividend. The ex-dividend date is Wednesday, September 14th. This represents a $2.56 dividend on an annualized basis and a yield of 6.30%.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Private Trust Co. NA acquired a new position in shares of BlackRock Health Sciences Trust in the 2nd quarter valued at $45,000. NewEdge Advisors LLC acquired a new position in shares of BlackRock Health Sciences Trust in the 2nd quarter valued at $390,000. Wells Fargo & Company MN raised its stake in shares of BlackRock Health Sciences Trust by 17.9% in the 2nd quarter. Wells Fargo & Company MN now owns 160,998 shares of the company’s stock valued at $6,827,000 after buying an additional 24,413 shares in the last quarter. LPL Financial LLC increased its position in shares of BlackRock Health Sciences Trust by 15.9% during the 2nd quarter. LPL Financial LLC now owns 56,793 shares of the company’s stock worth $2,408,000 after purchasing an additional 7,785 shares in the last quarter. Finally, UBS Group AG increased its position in shares of BlackRock Health Sciences Trust by 25.2% during the 2nd quarter. UBS Group AG now owns 159,864 shares of the company’s stock worth $6,778,000 after purchasing an additional 32,162 shares in the last quarter.

BlackRock Health Sciences Trust Company Profile

(Get Rating)

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.

Featured Stories

Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.